Sanara MedTech Inc. (SMTI)

Sanara MedTech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2.83	5.15	8.96	18.65	0.46	6.61
Cash & Cash Equivalents	2.83	5.15	8.96	18.65	0.46	6.61
Cash Growth	-61.18%	-42.55%	-51.97%	3996.23%	-93.11%	3647.81%
Receivables	9.22	8.53	7	2.99	2.27	1.34
Inventory	4.23	4.72	3.55	2.05	1.15	0.75
Other Current Assets	0.91	0.61	1.1	0.92	0.61	0.16
Total Current Assets	17.19	19.01	20.62	24.61	4.48	8.86
Property, Plant & Equipment	3.09	3.25	2.22	2.04	1.15	0.79
Long-Term Investments	3.08	3.08	3.08	5.02	1.1	0
Goodwill and Intangibles	47.56	48.53	35.11	4.73	3.1	1.47
Total Long-Term Assets	53.73	54.87	40.42	11.79	5.34	2.26
Total Assets	70.91	73.87	61.04	36.4	9.83	11.12
Accounts Payable	1.28	2	1.43	0.59	0.49	0.41
Current Debt	1.31	0.94	0.31	0.2	0.13	0.12
Other Current Liabilities	10.16	10.82	11.07	5.23	2.92	2.12
Total Current Liabilities	12.75	13.77	12.81	6.02	3.54	2.64
Long-Term Debt	10.39	10.85	0.51	0.22	0.36	1.98
Other Long-Term Liabilities	4.76	4.66	6	0	0.09	0.1
Total Long-Term Liabilities	15.15	15.52	6.51	0.22	0.45	2.08
Total Liabilities	27.9	29.28	19.32	6.24	3.99	4.72
Total Debt	11.7	11.79	0.82	0.43	0.48	2.1
Debt Growth	453.83%	1339.42%	92.56%	-11.62%	-77.07%	-
Retained Earnings	-29.9	-28.04	-23.39	-15.24	-7.03	-2.68
Shareholders' Equity	43.29	44.83	41.83	30.64	6.15	6.61
Net Cash / Debt	-8.87	-6.64	8.14	18.23	-0.03	4.51
Net Cash / Debt Growth	-	-	-55.34%	-	-	2458.09%
Net Cash Per Share	-1.05	-0.80	1.03	2.48	-0.00	2.12
Working Capital	4.44	5.24	7.81	18.59	0.94	6.22
Book Value Per Share	5.14	5.42	5.29	4.17	1.07	3.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).